The reverse stock split was approved by Intelligent Bio Solutions' stockholders at the annual meeting of the Company's stockholders held on October 16, 2025, with the final ratio to be determined by ...

Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its ...

NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time ...

Intelligent Bio Solutions forecasts a 32.6% profit increase, driven by higher-margin cartridge sales and market expansion efforts. Intelligent Bio Solutions Inc. announced preliminary unaudited ...

Intelligent Bio Solutions Inc. (INBS) shares soared 20% in Wednesday’s pre-market trade after the company announced a new ...

NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company developing and delivering intelligent, non-invasive, real-time ...

NEW YORK – Captured Venezuelan President Nicolás Maduro pleaded not guilty in a Manhattan federal court Jan. 5 to charges that he led a conspiracy to transport thousands of tons of cocaine into the ...

The collaboration will enable Intelligent Bio Solutions to scale production of its breakthrough drug-screening device to meet ...

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, ...

Intelligent Bio Solutions Inc. (INBS) announced the successful collection of new data that reinforces the performance of its Intelligent Fingerprinting Drug Screening System, which is crucial for its ...